PSI Newsletter 2022

Browse our 2022 PSI Newsletters. 

training to become a pharmacist

PSI Newsletter: Issue 1, 2022

Read the updates and insights in the PSI Newsletter: Issue 1, 2022

  • Learning from an Inquiry
  • Registration: Late fee notifications will apply from May
  • FMD latest updates
  • National Veterinary Prescription System Phased Implementation update
  • Legislative amendments and fitness to practise publications
  • Fitness to Practise and Mediation Outcomes
  • Updated HSE Infection Control Guidance
  • NSAI Legal Metrology Inspections
  • Valproate resources for patients and healthcare professionals
  • Lithium patient information booklet
  • IPU Workforce Survey
  • Effective donation of medicines to Ukraine

PSI Newsletter: Issue 2, 2022

Read the updates and insights in the PSI Newsletter: Issue 2, 2022

  • Introduction from the Interim Registrar and Chief Officer
  • Changes to the Anaphylaxis chapter for the Immunisation Guidelines for Ireland
  • Falsified Medicines Directive
  • Valproate resources for patients and pharmacists
  • Pharmacy workforce project and registration portal updates
  • Reminder: Advice on controlled drug compliance
  • Updated Inspection and Enforcement Policy
  • Reminder: Monitoring conditions of medicines
  • PSI Council appointments
  • Reminder: Update supervising and superintendent details in registration portal
  • Recruitment: PSI Chief Officer/Registrar
  • Review of the Core Competency Framework
  • Ensuring continuity of care: pharmacists’ roles and responsibilities

PSI Newsletter: Issue 3, 2022

Read the updates and insights in the PSI Newsletter: Issue 3, 2022

  • Opportunities to contribute to pharmacy workforce project
  • Guidance on non-prescription codeine products
  • Communication when dealing with vulnerable patients
  • Medication without harm and resources
  • AMRIC antimicrobial guidance and resources
  • Vaccination guidance and training reminders
  • Fitness to practise outcomes
  • Strong customer authentication and continued registration
  • National lithium information booklet for patients
  • Topiramate review- HPRA drug safety newsletter

PSI Newsletter: Issue 4, 2022

Read the updates and insights in the PSI Newsletter: Issue 4, 2022

  • End of year message
  • New Registrar/Chief Officer appointment
  • Pharmacy workforce project
  • Important medicines safety updates approved by HPRA
  • Falsified Medicines Directive reminder about pharmacy guides/SOPs
  • New Core Competency Framework for pharmacists in 2023
  • Fitness to Practise outcomes
  • Valproate (Epilim) PREVENT programme
  • ePortfolio Review reminder 2022/3
  • PSI Registration update